Epic Code LAB786 Granulocyte Antibodies, Serum
Additional Codes
Mayo Code: LAGGT
Interface Order Alias: 10391
Cerner: 8607
Performing Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Work-up of individuals having febrile, nonhemolytic transfusion reactions
Detection of individuals with autoimmune neutropenia
This test is not useful for the diagnosis of neutropenia caused by marrow suppression by drugs or tumors.
Specimen Type
Serum RedCOLLECTION NOTE: Volumes listed are in serum or plasma, draw approximately 2 1/2 times the requested volume in whole blood.
Specimen Required
Collection Container/Tube: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1.5 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Additional Information: Only pretransfusion reaction specimen is acceptable.
COLLECTION NOTE: Volumes listed are in serum or plasma, draw approximately 2 1/2 times the requested volume in whole blood.
Specimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Refrigerated (preferred) | 30 days | |
Frozen | 365 days | ||
Ambient | 7 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Day(s) Performed
Tuesday, Wednesday, Friday
Reference Values
Not applicable
Clinical Information
Granulocyte antibodies are induced by pregnancy or prior transfusion and are associated with febrile, nonhemolytic transfusion reactions. Patients who have been immunized by previous transfusions, pregnancies, or allografts frequently experience febrile, nonhemolytic transfusion reactions that must be distinguished from hemolysis before further transfusions can be safely administered. Granulocyte antibodies may also be present in autoimmune neutropenia.
Cautions
No significant cautionary statements
Interpretation
A positive result in an individual being worked up for a febrile transfusion reaction indicates the need for leukocyte-poor (filtered) red blood cells.
This test cannot distinguish between allo- and autoantibodies
Reporting Name
Granulocyte Ab, SMethod Name
Indirect Immunofluorescence
Method Description
Purified granulocyte preparations from normal donors are incubated with patient's test serum and then with fluorescein-tagged antihuman globulin reagent. Sera containing the antibodies deposit immunoglobulin on the target cell membrane, which is detected by the second stage antibody and visualized by fluorescence microscopy.(Verheugt FW, von dem Borne AE, Decary F, Engelfreit CP. The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol. 1997;36(4):533-534)
CPT Code Information
86021
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
LAGGT | Granulocyte Ab, S | 35279-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
LAGG | Granulocyte Ab, S | 35279-9 |
Report Available
7 to 15 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Clinical Reference
1. Flesch BK, Reil A. Molecular genetics of the human neutrophil antigens. Transfus Med Hemother. 2018;45(5):300-309. doi:10.1159/000491031
2. Gottschall JL, Triulzi DJ, Curtis B, et al. The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion. 2011;51(4):820-827. doi:10.1111/j.1537-2995.2010.02913.x